Ontology highlight
ABSTRACT: Background
Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable subtype-specific risk estimates are lacking.Methods
We used a panel of 34 putative susceptibility genes to perform sequencing on samples from 60,466 women with breast cancer and 53,461 controls. In separate analyses for protein-truncating variants and rare missense variants in these genes, we estimated odds ratios for breast cancer overall and tumor subtypes. We evaluated missense-variant associations according to domain and classification of pathogenicity.Results
Protein-truncating variants in 5 genes (ATM, BRCA1, BRCA2, CHEK2, and P
SUBMITTER: Breast Cancer Association Consortium
PROVIDER: S-EPMC7611105 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature